Cargando…
Chemokine Receptors CCR6 and PD1 Blocking scFv E27 Enhances Anti-EGFR CAR-T Therapeutic Efficacy in a Preclinical Model of Human Non-Small Cell Lung Carcinoma
Chimeric antigen receptor (CAR)-T cells, a therapeutic agent for solid tumors, are not completely effective due to a lack of infiltration of T cells into the tumor site and immunity caused by Programmed Death Receptor 1(PD1). Here, an epidermal growth factor receptor (EGFR) CAR-T cell was engineered...
Autores principales: | Wang, Jing, Wang, Yanan, Pan, Hanyu, Zhao, Lin, Yang, Xinyi, Liang, Zhiming, Shen, Xiaoting, Zhang, Jing, Yang, Jinlong, Zhu, Yuqi, Xun, Jingna, Liang, Yue, Lin, Qinru, Liang, Huitong, Li, Min, Zhu, Huanzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056525/ https://www.ncbi.nlm.nih.gov/pubmed/36982500 http://dx.doi.org/10.3390/ijms24065424 |
Ejemplares similares
-
Allogeneic gene-edited HIV-specific CAR-T cells secreting PD-1 blocking scFv enhance specific cytotoxic activity against HIV Env(+) cells invivo
por: Pan, Hanyu, et al.
Publicado: (2023) -
Identification of Potent CD19 scFv for CAR T Cells through scFv Screening with NK/T-Cell Line
por: Kang, Chung Hyo, et al.
Publicado: (2020) -
Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
por: Wang, Yanan, et al.
Publicado: (2021) -
scFv Antibody: Principles and Clinical Application
por: Ahmad, Zuhaida Asra, et al.
Publicado: (2012) -
FBXO34 promotes latent HIV-1 activation by post-transcriptional modulation
por: Yang, Xinyi, et al.
Publicado: (2022)